Arthur Suckow, co-founder and CEO of DTx Pharma, discusses the delivery challenge of RNA therapies, how DTx’s platform technology addresses these, and how a $100 million financing from earlier this year will be used to fuel its growth.

Targeting Tissues Throughout the Body with RNA Therapies

<p>RARECast is a Global Genes podcast hosted by award-winning journalist Daniel Levine. It focuses on the intersection of rare disease with business, science, and policy. </p>

Business

RARECast is a Global Genes podcast hosted by award-winning journalist Daniel Levine. It focuses on the intersection of rare disease with business, science, and policy.

Share Targeting Tissues Throughout the Body with RNA Therapies

Sign up to save your podcasts

Targeting Tissues Throughout the Body with RNA Therapies

Targeting Tissues Throughout the Body with RNA Therapies